Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 484, pseudogene (RN7SL484P) is a **pseudogene** of the 7SL RNA family. The 7SL RNA is the RNA component of the signal recognition particle (SRP), which is essential for targeting newly synthesized proteins to the endoplasmic reticulum in eukaryotes[1][3][5]. However, RN7SL484P itself is classified as a *pseudogene*, meaning it is a non-functional copy of a gene that generally does not produce a functional product, and does not participate in SRP activity[4]. Pseudogenes like RN7SL484P may sometimes act as regulatory non-coding RNAs, influencing expression of related genes through sequence similarity, but direct functional or disease relevance for RN7SL484P is not established in the current scientific literature[2][4]. This pseudogene is not recognized as a therapeutic target, biomarker, or druggable entity. **Notes:** - Is_incorrect is marked as true because this entity is a pseudogene, not an active molecular target such as a receptor, enzyme, or transporter, and lacks established biological activity or direct relevance as a therapeutic target[4]. - Most structured databases and primary resources only confirm RN7SL484P as a transcriptionally silent non-coding pseudogene; detailed functional data or disease associations are lacking[4]. - For related entries, 7SL RNA (RN7SL1) is the functional molecule in the SRP complex, not RN7SL484P[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 484, pseudogene (RN7SL484P).